House panel sets second hearing in J&J recall probe, releases email on “pahntom” Motrin recall
By APThursday, September 16, 2010
House panel sets 2nd hearing in J&J recall probe
WASHINGTON — A congressional committee investigating repeated recalls of Johnson & Johnson nonprescription medicines has scheduled a second hearing on the case and invited the company’s CEO, who sent a subordinate to the last one.
The committee also released some internal J&J e-mails it uncovered indicating that before all the official recalls of the last year, the company conducted a “phantom recall” of Motrin packages with questionable potency.
J&J allegedly paid a third party to secretly pull the Motrin packets off store shelve — with the blessing of federal regulators, one e-mail indicates.
J&J’s once-golden reputation has been severely tarnished by 11 recalls of medicines, contact lenses and hip implants in as many months.
